Copyright
©2016 Baishideng Publishing Group Co.
World J Nephrol. Mar 6, 2016; 5(2): 213-219
Published online Mar 6, 2016. doi: 10.5527/wjn.v5.i2.213
Published online Mar 6, 2016. doi: 10.5527/wjn.v5.i2.213
Table 1 Socio-demographic characteristics of study sample (89 patients)
Variable | n (%) | Mean (SD) |
Current age (yr) | 11.3 (4.12) | |
1-4 | 1 (1.1) | |
5-9 | 30 (33.7) | |
10-14 | 36 (40.4) | |
15-18 | 22 (24.7) | |
Gender | ||
Male | 51 (57.3) | |
Female | 38 (42.7) | |
Race | ||
Malay | 76 (85.4) | |
Chinese | 9 (10.1) | |
Others | 4 (4.5) | |
Aetiology | ||
Glomerular | 61 (68.5) | |
CAKUT | 20 (22.5) | |
Tubulointerstitial | 8 (9.0) |
Table 2 Anthropometric, clinical and laboratory characteristics of the study sample
Variable | n | n (%) | Mean (SD) | Median (IQR) |
Weight in kilogram | 87 | - | 29.90 (23.60)1 | |
< 5th percentile | 22 (25.3) | |||
≥ 5th percentile | 65 (74.7) | |||
Height in cm | 74 | - | 123.70 (27.60)2 | |
< 5th percentile | 23 (31.1) | |||
≥ 5th percentile | 51 (68.9) | |||
Systolic blood pressure (mmHg) | 79 | 111.8 (13.86) | - | |
Diastolic blood pressure (mmHg) | 79 | 70.9 (10.40) | - | |
Normal | 40 (50.6) | |||
Pre-hypertensive | 12 (15.2) | |||
Stage 1 hypertension | 21 (26.6) | |||
Stage 2 hypertension | 6 (7.6) | |||
Haemoglobin level (g/dL) | 82 | 12.7 (1.65) | - | |
Normal | 63 (76.8) | |||
Anaemia | 19 (23.2) | |||
eGFR (mL/min per 1.73 m2) | 86 | 124.6 (52.99) | - | |
Stage 1 (> 90) | 70 (81.4) | |||
Stage 2 (60-89) | 6 (7.0) | |||
Stage 3 (30-59) | 4 (4.7) | |||
Stage 4 (15-29) | 2 (2.3) | |||
Stage 5 (< 15) | 4 (4.7) | |||
Proteinuria | 82 | - | - | |
Yes | 42 (51.2) | |||
No | 40 (48.8) | |||
Haematuria | 82 | - | - | |
Yes | 21 (25.6) | |||
No | 61 (74.4) |
Table 3 Correlation between glomerular filtration rate, current age and age of diagnosis with weight and height
Table 4 Relationship between gender and aetiology with weight and height
Weight | χ2 statistic (df) | P value1 | Height | χ2 statistic (df) | P value1 | |||
< 5th percentile | ≥ 5th percentile | < 5th percentile | ≥ 5th percentile | |||||
n (%) | n (%) | n (%) | n (%) | |||||
Gender | ||||||||
Male | 9 (17.6) | 42 (82.4) | 3.81 | 0.051 | 10 (21.7) | 36 (78.3) | 4.95 | 0.026 |
Female | 13 (36.1) | 23 (63.9) | (1) | 13 (46.4) | 15 (53.6) | (1) | ||
Aetiology | ||||||||
Glomerular | 9 (15.0) | 51 (85.0) | 10.83 | 0.001 | 10 (20.0) | 40 (80.0) | 8.84 | 0.003 |
Non-glomerular | 13 (48.1) | 14 (51.9) | (1) | 13 (54.2) | 11 (45.8) | (1) |
Table 5 Comparisons of paediatric epidemiological data from different countries from 1990-2015
Period | No. of patients | Main aetiology | Male/female ratio | Mean age at diagnosis | GFR/CKD stage | Incidence | Prevalence | |
Brunei | 2004-2013 | 89 | GN (69%) | 1.3 | 4.5 | Mainly CKD 1 (81%) | 91 | 736 (CKD1) |
132 (CKD2 and above) | ||||||||
83 (CKD3 and above) | ||||||||
50 (CKD4 and above) | ||||||||
33 (CKD5) | ||||||||
Italy[10] | 1990-2000 | 1197 | CAKUT (58%) | 2.0 | 6.9 | GFR 42 (mean) | 12.1 | 75 |
Belgium[11] | 2001-2005 | 143 | CAKUT (59%) | 1.3 | 3.0 | Mainly CKD 3 (67%) | 11.9 | 56 |
Spain[12] | 2007-2008 | 605 | 1.9 | 3.9 | GFR 52 (mean) | 8.7 | 71 | |
United States[15] | 1994-2007 | 7037 | CAKUT (48%) | |||||
Kuwait[16] | 1996-2003 | 171 | CAKUT 62% | 2.7 | 33 mo | 30% of patient reached ESRD within 18 mo of diagnosis | 38-55 | |
Vietnam[17] | 2001-2005 | 152 | 1.7 | 11.3 | 65% received RRT | 5.1 | ||
Sudan[18] | 2001-2006 | 205 | GN 25% | 1.7 | 9.8 | 63% of cohort reached ESRD during the follow up period | ||
Turkey[19] | 2005 | 282 | “Urological problem” 44.3% | 1.3 | 8.0 | CKD2-5 | 11.9 | |
Thailand[20] | 1982-2005 | 101 | GN 35% | 1.6 | Not rare | Double in last 6 yr of research | ||
Jordan[21] | 1988-2001 | 202 | CAKUT 42% | 1.3 | 7.5 | 59/202 patients require RRT | 10.7 | 51 |
China[22] | 1990-2002 | 1658 | GN 52% | 1.5 | 8.18 | Mean serum creatinine 594.7 mmol/L |
- Citation: Tan SY, Naing L, Han A, Khalil MAM, Chong VH, Tan J. Chronic kidney disease in children and adolescents in Brunei Darussalam. World J Nephrol 2016; 5(2): 213-219
- URL: https://www.wjgnet.com/2220-6124/full/v5/i2/213.htm
- DOI: https://dx.doi.org/10.5527/wjn.v5.i2.213